251 related articles for article (PubMed ID: 1360720)
1. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of epidermal growth factor receptor and c-erbB-2 oncogene product in human ovarian carcinoma.
Ito K; Sasano H; Ozawa N; Sato S; Silverberg SG; Yajima A
Int J Gynecol Pathol; 1992 Oct; 11(4):253-7. PubMed ID: 1356938
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor in normal ovary and in ovarian tumors.
Stewart CJ; Owens OJ; Richmond JA; McNicol AM
Int J Gynecol Pathol; 1992 Oct; 11(4):266-72. PubMed ID: 1399232
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-3 protein expression in ovarian tumours.
Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
[TBL] [Abstract][Full Text] [Related]
6. c-erbB growth-factor-receptor proteins in ovarian tumours.
Simpson BJ; Phillips HA; Lessells AM; Langdon SP; Miller WR
Int J Cancer; 1995 Jun; 64(3):202-6. PubMed ID: 7622309
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor and c-erbB-2 oncoproteins in tissue and tumor effusion cells of histopathologically different ovarian neoplasms.
Harlozińska A; Bar JK; Sobańska E; Goluda M
Tumour Biol; 1998; 19(5):364-73. PubMed ID: 9701727
[TBL] [Abstract][Full Text] [Related]
8. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
Kommoss F; Colley M; Hart CE; Franklin WA
Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
[TBL] [Abstract][Full Text] [Related]
9. Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor.
Scambia G; Catozzi L; Panici PB; Ferrandina G; Coronetta F; Barozzi R; Baiocchi G; Uccelli L; Piffanelli A; Mancuso S
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):71-8. PubMed ID: 8420353
[TBL] [Abstract][Full Text] [Related]
10. p53 protein expression in putative precursor lesions of epithelial ovarian cancer.
Hutson R; Ramsdale J; Wells M
Histopathology; 1995 Oct; 27(4):367-71. PubMed ID: 8847068
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma.
van Dam PA; Vergote IB; Lowe DG; Watson JV; van Damme P; van der Auwera JC; Shepherd JH
J Clin Pathol; 1994 Oct; 47(10):914-9. PubMed ID: 7962604
[TBL] [Abstract][Full Text] [Related]
12. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
[TBL] [Abstract][Full Text] [Related]
14. Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta.
Wang DP; Fujii S; Konishi I; Nanbu Y; Iwai T; Nonogaki H; Mori T
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):385-93. PubMed ID: 1375794
[TBL] [Abstract][Full Text] [Related]
15. The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma.
Skirnisdóttir I; Sorbe B; Seidal T
Int J Gynecol Cancer; 2001; 11(2):119-29. PubMed ID: 11328410
[TBL] [Abstract][Full Text] [Related]
16. Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study.
Suo Z; Karbovo E; Trope CG; Metodiev K; Nesland JM
Ultrastruct Pathol; 2004; 28(3):141-7. PubMed ID: 15471427
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
Schmandt RE; Broaddus R; Lu KH; Shvartsman H; Thornton A; Malpica A; Sun C; Bodurka DC; Gershenson DM
Cancer; 2003 Aug; 98(4):758-64. PubMed ID: 12910520
[TBL] [Abstract][Full Text] [Related]
18. Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin.
Skubitz AP; Bast RC; Wayner EA; Letourneau PC; Wilke MS
Am J Pathol; 1996 May; 148(5):1445-61. PubMed ID: 8623916
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor in normal ovaries and benign ovarian tumours.
Owens OJ; Leake RE
Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):229-33. PubMed ID: 1294410
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts.
Okamoto S; Okamoto A; Nikaido T; Saito M; Takao M; Yanaihara N; Takakura S; Ochiai K; Tanaka T
Oncol Rep; 2009 May; 21(5):1209-14. PubMed ID: 19360296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]